A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family

Cancer Research

Volumn 58, Issue 7, 1998, Pages 1372-1375

  Nordling, Margareta ^a   Karlsson, Per ^a   Wahlström, Jan ^a   Engwall, Yvonne ^a   Wallgren, Arne ^a   Martinsson, Tommy ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER FAMILY; CANCER SUSCEPTIBILITY; CASE REPORT; CHROMOSOME 13Q; CHROMOSOME 17Q; FEMALE; GENE DELETION; GENETIC SUSCEPTIBILITY; HUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BASE SEQUENCE; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA, NEOPLASM; EXONS; FAMILY HEALTH; FEMALE; GENE DELETION; GERM-LINE MUTATION; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PEDIGREE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0032054311     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Miki, Y. J., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosental, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, R., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Morris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266: 66-71, 1994.
2. Wooster, R. S. L., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., Fields, P., Marshall, G., Narod, S., Lenoir, G. M., Lynch, H., Feunteun, J., Devilee, P., Cornelisse, C. J., Menko, F. H., Daly, P. A., Ormiston, W., McManus, R., Pye, C., Lewis, C. M., Cannon-Albright, L. A., Peto, J., Ponder, B. A. J., Skolnick, M. H., Easton, D. F., Goldgar, D. E., and Stratton, M. R. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (Washington DC), 265: 2088-2090, 1994.
3. Vard, A., Monteiro, A. N., August, A., and Hanafusa, H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA, 93: 13595-13599, 1996.
4. Milner, J. B., Ponder, B., Hughes-Davies, L., Seltmann, M., and Kouzarides, T. Transcriptional activation functions in BRCA2. Nature (Lond.), 386: 72-773, 1997.
5. Shinohara, A., Ogawa, H., Matsuda, Y., Ushio, N., Ikeo, K., and Ogawa, T. Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nat. Genet., 4: 239-243, 1993.
6. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88: 265-275, 1997.
7. Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D. S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (Lond.), 386: 804-810, 1997.
8. Peelen, T., van Vliet, M., Petrij-Bosch, A., Mieremet, R., Szabo, C., van den Ouweland, A. M., Hogervorst, F., Brohet, R., Ligtenberg, M. J., Teugels, E., van der Luijt, R., van der Hout, A. H., Gille, J. J., Pals, G., Jedema, I., Olmer, R., van Leeuwen, I., Newman, B., Plandsoen, M., van der Est, M., Brink, G., Hageman, S., Arts, P. J., Bakker, M. M., Willems, H. W., van der Loij, E., Neyns, B., Bonduelle, M., Meijers-Heijboer, H., Klijn, J. G. M., de Greve, J., King, M-C., Menko, F. H., Brunner, H. G., Halley, D., van Ommen, G-J. B., Vasen, H. F. A., Cornelisse, C. J., van't Veer, L. J., de Knijff, P., Bakker, E., and Devilee, P. A high proportion of novel mutations in BKCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am. J. Hum. Genet., 60: 1041-1049, 1997.
9. Phelan, C. M., Lancaster, J. M., Tonin, P., Gumbs, C., Cochran, C., Carter R; Ghadirian, P., Perret, C., Moslehi, R., Dion, F., Faucher, M. C., Dole, K., Karimi, S., Foulkes, W., Lounis, H., Warner, E., Goss, P., Anderson, D., Larsson, C., Narod, S. A., and Futreal, P. A. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat. Genet., 12: 333-337, 1996.
10. Petrij-Bosch, A., Peelen, T., van Vliet, M., van Eijk, R., Olmer, R., Drüsedau, M., Hogervorst, F. B. L., Hageman, S., Arts, P. J. W., Ligtenberg, M. J. L., Meijers-Heijboer, H., Klijn, J. G. M., Vasen, H. F. A., Conelisse, C. J., van't Veer, L. J., Bakker, E., van Ommen, G-J. B., and Devilee, P. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat. Genet., 17: 341-345, 1997.
11. Hogervorst, F. B., Cornelis, R. S., Bout, M., van Vliet, M., Oosterwijk, J. C., Olmer, R., Bakker, B., Klijn, J. G., Vasen, H. F., Meijers-Heijboer, H., Menko, F. H., Cornelisse, C. J., den Dunnen, J. T., Devilee, P., and van Ommen, G-J. B. Rapid detection of BRCA1 mutations by the protein truncation test. Nat. Genet., 10: 208-212, 1995.
12. Håkansson, S. O., Johannsson, O., Johansson, U., Scllberg, G., Loman, N., Gerdes, A. M., Holmberg, E., Dahl, N., Pandis, N., Kristoffersson, U., Olsson, H., and Borg, A. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am. J. Hum. Genet., 60: 1068-1078, 1997.
13. Roest, P. A., Roberts, R. G., Sugino S., van Ommen G. J., and den Dunnen, J. T. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum. Mol. Genet., 2: 1719-1721, 1993.
14. Baserga, T. J., and Benz, E. J., Jr. β-Globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability. Proc. Natl. Acad. Sci. USA, 89: 2935-2939, 1992.
15. Kohonen-Corish, M., Ross, V. L., Doe, W. F., Kool, D. A., Edkins, E., Faragher, I., Wijnen, J., Khan, P. M., Macrae, F., and St. John, D. J. RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am. J. Hum. Genet., 59: 818-824, 1996.
16. Dobrovic, A., and Simpfendorfer, D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res., 57: 3347-3350, 1997.
17. Marcus, J. N., Page, D. L., Watson, P., Narod, S. A., Lenoir, G. M., and Lynch, H. T. BRCA1 and BRCA2 hereditary breast carcinoma phenotypes. Cancer (Phila.), 80: 543-556, 1997.
18. Lakhani, S. R., Easton, D. F., Stratton, M. R., Storferisser, A., Anderson, T. J., Fand, L. M., Gusterson, B. A., Jaquemier, J., Sloane, J. P., Venter, D., Vandevijver, M. J., Bishop, D. T., Barkardottir, R. B., Bignon, Y. J., Cornelisse, C., Changclaude, J., Daly, P. A., Devilee, P., Egilsson, V., Ford, D., Goldgar, D., Haites, N., Hamann, U., Klijn, J. G. M., Lasset, C., Lenoir, G., McManus, R., Neuhausen, S., Ormiston, W., Ponder, B. A. J., Peto, J., Steel, C. M., Stoppalyonnet, D., Smyth, E., Sobol, H., Spurr, N. K., Scott, R. J., Scherneck, S., Streuwing, J. P., Vasen, H., and Weber, B. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet, 349: 1505-1510, 1997.
19. Puget, N., Torchard, D., Serova-Sinilnikova, O. M., Lynch, H. T., Feunteun, J., Lenoir, G. M., and Mazoyer, S. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res., 57: 828-831, 1997.
20. Swensen, J., Huffman, M., Skolnick, M. H., and Neuhausen, S. L. Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum. Mol. Genet., 6: 1513-1517, 1997.